AI for global health: From product development to policy
2 June 2026, 1:00 pm – 2:30 pm
Location: Online
Think tank: Institute of Development Studies
This event hosted by UK think tank the Institute of Development Studies takes stock of where AI is shifting the dial in global health.
Artificial intelligence is moving rapidly from research labs into the hands of community health workers, clinics, and public health programmes that shape outcomes for billions of people. But, how do we know a product is ready for deployment – and who gets to decide?
This event, brought to you by the IDS-led Knowledge for Development and Diplomacy programme (K4DD), takes stock of where AI is shifting the dial in global health, and where the hype outpaces the evidence. AI-enabled tools are being piloted across triage, diagnostics, health worker support and patient engagement, while questions about data, equity, clinical safety and governance have moved to the centre of the policy conversation.
The session brings together practitioners, researchers, funders and regulators to move from foundations to frontline evidence. Following opening remarks from FCDO, Audere will deliver an “AI 101” for global health audiences, followed by a real-world clinical trial case study from the London School of Hygiene and Tropical Medicine and a fireside chat with the Gates Foundation on what rigorous evidence generation looks like in practice. The session will close with reflections from an African regulatory leader (TBC) and a Q&A session moderated by PATH.
The webinar will also mark the launch of a new K4DD guide on how to assess AI4health programmes – a practical framework to help policymakers, funders and programme managers evaluate AI-enabled health interventions. The guide offers a practical framework for interrogating claims, weighing evidence, and asking the right questions about safety, equity, performance, and value for money. It will be available on the K4DD website soon.
This event aims to support more evidence-based, context-relevant approaches to deploying, evaluating and governing AI in global health.
Speakers
Kerry Millington – Global Health Researcher, Liverpool School of Tropical Medicine and K4DD
Meena Gandhi – Health Head of Profession, Research and Evidence Directorate, Foreign, Commonwealth and Development Office
Dino Rech – CEO and Founder, Audere (AI 101).
Ambrose Agweyu – Professor, London School of Hygiene and Tropical Medicine
Melissa Miles – Senior Program Officer, Gates Foundation
Maelle-Marie Troadec – Regulatory Fellow, PATH
Regulatory Leader (TBC)